JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
Release Date:
Ron Witteles, MD, and and Andrew Nguyen, MD, discuss the study design and findings of HELIOS-B, and clinical impact of vutrisiran in transthyretin amyloid cardiomyopathy.
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy